Related content

Ovarian hormones and reproductive risk factors for breast cancer in premenopausal women: the Norwegian EBBA-I study

By Iversen A.   Thune I.   McTiernan A.   Emaus A.   Finstad S.E.   Flote V.   Wilsgaard T.   Lipson S. F.   Ellison P.T.   Jasienska G.   Furberg A.-S.  

Human Reproduction, Vol. 26, Iss. 6, 2011-06 ,pp. : 1519-1529

Oxford University Press

Access to resources Recommend Favorite

Unchanged asymmetric dimethylarginine levels in non-diabetic, premenopausal obese women who have common risk factors for cardiovascular disease

By Cetinalp-Demircan P.   Can A.   Bekpinar Selda   Unlucerci Y.   Orhan Y.  

Endocrine Journal, Vol. 31, Iss. 2, 2007-04 ,pp. : 100-104

Humana Press, Inc

Access to resources Recommend Favorite

Long-term oral contraceptive treatment, metabolic syndrome and measures of cardiovascular risk in pre-menopausal women: National Health and Nutrition Examination Survey 1999-2004

By Hurwitz Barry   Henry Nicole   Goldberg Ronald  

Gynecological Endocrinology, Vol. 25, Iss. 7, 2009-07 ,pp. : 441-449

Informa Healthcare

Access to resources Recommend Favorite

Effects of hyperprolactinemia on osteoporotic fracture in premenopausal women

By Vartej P.   Poiana C.   Vartej I.  

Gynecological Endocrinology, Vol. 15, Iss. 1, 2001-02 ,pp. : 43-47

Informa Healthcare

Access to resources Recommend Favorite

Effect of risedronate on biochemical marker of bone resorption in postmenopausal women with osteoporosis or osteopenia

By Dane Cem   Dane Banu   Cetin Ahmet   Erginbas Murat  

Gynecological Endocrinology, Vol. 24, Iss. 4, 2008-01 ,pp. : 207-213

Informa Healthcare

Access to resources Recommend Favorite